Vir Biotechnology Narrows Third-Quarter Net Loss to $96.3 Million

The company’s loss per share was $0.57, compared with $1.17 a year earlier. Cash, cash equivalents and investments totaled about $901.3 million at Sept. 30.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.